Nancy A. Grygiel, Senior Vice President and Chief Compliance Officer at Amgen Inc . (NASDAQ:AMGN), recently sold shares of the company's common stock. According to a filing with the Securities and ...
Amgen Inc.'s ( NASDAQ:AMGN ) dividend will be increasing from last year's payment of the same period to $2.38 on 7th ...
Amgen posted strong earnings beat and has an attractive dividend, and technical chart forecasting positive future performance ...
Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...
Today, Benzinga 's options scanner spotted 28 uncommon options trades for Amgen. This isn't normal. The overall sentiment of ...
Amgen's Q4 earnings beat expectations, showcasing robust performance for the company's growth strategy. Click here to read ...
RBC Capital analyst Gregory Renza maintained a Buy rating on Amgen (AMGN – Research Report) yesterday and set a price target of $320.00. The ...
Several other research analysts have also issued reports on the stock. Deutsche Bank Aktiengesellschaft cut their target price on shares of Amgen from $305.00 to $285.00 in a research report on ...
Amgen stock prices rose nearly 1.5% in the trading session following the release of its mixed Q3 results on Oct. 30. Driven by a significant surge in volumes and the acquisition of Horizon ...
Shares of the company began plunging in November, but its overall strength should set the stock up for some serious potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback